Related Experiment Videos
[Ophthalmic complications in general corticoid therapy].
M Porubská1, B Krchnavá, J Slámová
1OLU RCH, Nový Smokovec.
Ceskoslovenska Oftalmologie
|November 1, 1991
Summary
Long-term corticosteroid therapy can lead to posterior subcapsular cataracts and elevated intraocular pressure (corticosteroid glaucoma). However, duration and dosage showed minimal influence, with individual sensitivity being key.
Area of Science:
- Ophthalmology
- Endocrinology
Context:
- Long-term systemic corticosteroid use is common for various inflammatory and autoimmune conditions.
- Ophthalmic side effects, including cataracts and glaucoma, are known risks associated with corticosteroid treatment.
Purpose:
- To investigate the impact of long-term systemic corticotherapy on lens transparency and intraocular pressure.
- To analyze the relationship between corticosteroid therapy parameters (duration, dosage, age, sex) and the incidence of posterior subcapsular cataract and corticosteroid glaucoma.
Summary:
- A study of 850 patients found posterior subcapsular cataracts in 5.2% and elevated intraocular pressure in 12.8%.
- Therapy duration did not significantly affect cataract or glaucoma development.
- A daily dose of 10-15 mg of corticosteroids was marginal for cataract development; dosage minimally impacted glaucoma.
- Complication incidence was highest in older age groups, with no sex predisposition.
- Individual sensitivity to corticosteroids plays a significant role in developing corticosteroid-induced eye conditions.
Impact:
- Highlights the importance of monitoring intraocular pressure and lens clarity in patients on long-term corticosteroids.
- Suggests that individual patient sensitivity is a critical factor in corticosteroid-induced ocular complications.
- Informs clinical practice regarding risk assessment and patient selection for prolonged corticosteroid therapy.